| Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
| Topical oral thymoxamine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| koronar vasodilatator |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Dipyridamole 50 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Dipyridamole 75 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| natriumnitroprussid 25 mg/ml injektionsvæske, opløsning, ampul |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| natriumnitroprussid 50 mg pulver til injektionsvæske, opløsning, hætteglas |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Product containing precisely guanethidine monosulfate 10 milligram/1 each conventional release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Guanethidine monosulfate 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Diazoxide 15mg/mL injection |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Product containing precisely diazoxide 50 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Guanethidine monosulfate 10 mg and hydrochlorothiazide 25 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Endothelin receptor antagonist |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Human B-type natriuretic peptide |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Treprostinil sodium (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Isosorbide (substance) |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Amyl nitrite (substance) |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Hydralazine (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Minoxidil (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Prenylamine (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Cyclandelate (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Nimodipine (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Nicorandil (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Oxerutins (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Naftidrofuryl |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Product containing tolazoline (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Product containing diazoxide (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| vasodilaterende middel |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Product containing dipyridamole (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Product containing guanethidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Product containing nitroprusside (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Poisoning by nitrite |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Tolazoline (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| guanethidinmonosulfat 10 mg/1 ml injektionsvæske |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| guanethidinmonosulfat 3 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| guanethidinmonosulfat 2 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| guanethidinmonosulfat 1 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| guanethidinmonosulfat 0,5 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| guanethidinmonosulfat 0,25 % øjendråber |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Guanethidine monosulfate [antihypertensive] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Guanethidine monosulfate [eye] |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| dipyridamol 50 mg/5 ml sukkerfri oral suspension |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| guanethidinmonosulfat + hydrochlorthiazid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| diazoxid 15 mg/ml injektionsvæske, opløsning, hætteglas a 20 ml |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Guanethidine monosulfate+epinephrine |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to coronary vasodilators NOS |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to other vasodilators |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to vasodilators NOS |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Product containing precisely dipyridamole 10 milligram/1 milliliter conventional release oral suspension (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Fenoldopam |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Xanthine |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Flosequinan (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Inositol nicotinate |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Xanthinol |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Alpha adrenergic receptor antagonist |
Is a |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Aminophylline (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Sodium nitroprusside (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Dipyridamole (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Betahistine (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| [X]Coronary vasodilators causing adverse effects in therapeutic use, not elsewhere classified |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Accidental diazoxide poisoning |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Intentional diazoxide poisoning |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Accidental nitrite poisoning |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Intentional nitrite poisoning |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Ranolazine (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Aviptadil (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Nesiritide (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Nitroprusside (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Levosimendan (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| allergi over for vasodilator |
Causative agent |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
1 |
| Molsidomine (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Adverse reaction to coronary vasodilator |
Causative agent |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
1 |
| Dihydralazine |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Trimetazidine |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Hexobendine (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Riociguat (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Product containing treprostinil (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Treprostinil 600 microgram/mL solution for inhalation |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| humant B-type natriuretisk peptid |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Product containing guanethidine in ophthalmic dosage form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Product containing epinephrine and guanethidine (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Selexipag (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Treprostinil (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Sodium nitroprusside dihydrate (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Aminophylline anhydrous |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Aminophylline hydrate |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Betahistine mesilate |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Guanadrel sulfate |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Moxisylyte hydrochloride (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Labetalol (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Indoramin (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Prazosin (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Alfuzosin (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Yohimbine hydrochloride |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Atipamezole (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Doxazosin (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Yohimbine |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Urapidil (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Moxisylyte |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Azapetine |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Terazosin hydrochloride |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
| Terazosin (substance) |
Is a |
True |
Vasodilator (substance) |
Inferred relationship |
Some |
|
FHIR